PuraPharm Corporation Balance Sheet

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	16.8	12.79	20.13	75.83	59.67	91.4
Short-Term Investments	33.09	24.1	22.85	15.53	36.39	41.15
Cash & Short-Term Investments	49.89	36.9	42.98	91.36	96.06	132.55
Cash Growth	-2.35%	-14.14%	-52.96%	-4.89%	-27.53%	33.05%
Accounts Receivable	37.95	57.5	80.87	131.87	261.41	221.53
Other Receivables	8.81	3.55	8.77	8.5	2.25	0.91
Receivables	46.76	61.04	89.64	140.37	263.65	222.43
Inventory	83.34	123.56	175.6	190.81	199.8	190.15
Prepaid Expenses	24.32	17.8	10.19	26.69	23.56	25.53
Restricted Cash	0.01	25.48	27.1	31.18	25.38	-
Other Current Assets	27.39	3.67	4.08	5.58	2.41	37.02
Total Current Assets	231.7	268.44	349.57	486	610.86	607.68
Property, Plant & Equipment	363.9	355.39	396.91	431.08	461.02	459.35
Long-Term Investments	3.43	3.7	2.96	1.2	-	-
Goodwill	17.94	17.94	17.94	20.99	20.99	88.34
Other Intangible Assets	29.7	31.56	34.74	37.64	41.06	42.92
Long-Term Deferred Tax Assets	7.29	7.7	8.82	11.05	10.48	11.29
Other Long-Term Assets	24.79	30.99	33.03	28.54	61.45	165
Total Assets	678.76	715.73	843.96	1,016	1,206	1,375
Accounts Payable	118.62	132.21	146.38	137.91	140.68	159.34
Short-Term Debt	112.55	199.45	250.8	353.7	362.05	211.29
Current Portion of Long-Term Debt	129.24	51.1	53.22	56.44	45.62	68.04
Current Portion of Leases	19.39	13.63	17.97	18.51	13.24	31.4
Current Income Taxes Payable	5.6	7.71	2.07	1.44	3.58	2.85
Current Unearned Revenue	0.16	0.17	0.17	0.25	2.34	2.75
Other Current Liabilities	62.24	86.8	100.48	97.16	97.81	116.22
Total Current Liabilities	447.79	491.07	571.09	665.41	665.31	591.89
Long-Term Debt	97.03	89.16	81.09	48.68	92	178.99
Long-Term Leases	16.25	10.42	21.68	25.83	19.05	34.39
Long-Term Unearned Revenue	2.38	1.9	1.08	1.03	1.17	3.85
Long-Term Deferred Tax Liabilities	1.36	0.97	1.74	3.02	2.61	3.24
Other Long-Term Liabilities	12.29	11.02	14.04	14.25	24.16	50.56
Total Liabilities	577.1	604.53	690.73	758.21	804.31	862.92
Common Stock	306.82	306.82	306.82	306.82	306.04	306.04
Additional Paid-In Capital	221.57	221.57	221.57	221.57	221.19	220.66
Retained Earnings	-415.94	-394.13	-358.69	-252.63	-133.03	-11.16
Comprehensive Income & Other	-10.8	-23.06	-16.47	-17.47	7.36	-3.89
Total Common Equity	101.66	111.2	153.24	258.29	401.56	511.66
Shareholders' Equity	101.66	111.2	153.24	258.29	401.56	511.66
Total Liabilities & Equity	678.76	715.73	843.96	1,016	1,206	1,375
Total Debt	374.45	363.76	424.77	503.16	531.96	524.11
Net Cash (Debt)	-324.56	-326.86	-381.8	-411.8	-435.9	-391.57
Net Cash Per Share	-0.82	-0.83	-0.97	-1.04	-1.11	-1.05
Filing Date Shares Outstanding	395.05	395.05	395.05	395.05	393.93	392.98
Total Common Shares Outstanding	395.05	395.05	395.05	395.05	393.93	392.98
Working Capital	-216.09	-222.63	-221.52	-179.41	-54.46	15.79
Book Value Per Share	0.26	0.28	0.39	0.65	1.02	1.30
Tangible Book Value	54.01	61.69	100.55	199.66	339.5	380.4
Tangible Book Value Per Share	0.14	0.16	0.25	0.51	0.86	0.97
Land	-	218.08	225.23	225.13	234.75	204.72
Machinery	-	197.51	204.33	203.97	203.05	177.83
Construction In Progress	-	68.99	69.18	71.28	77.66	85.78
Leasehold Improvements	-	29.76	15.7	16.51	24.31	40.62

Source: S&P Global Market Intelligence. Standard template. Financial Sources.